Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pennon Group PLC Remuneration Information 2020

Aug 3, 2020

4705_def-14a_2020-08-03_226803a2-45c1-42ab-bdd4-1d57b680bf69.html

Remuneration Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 9706U

Pennon Group PLC

03 August 2020

BLOCK LISTING SIX MONTHLY RETURN

Date:  3 August 2020

Name of applicant: PENNON GROUP PLC
Name of scheme: PENNON GROUP SHARESAVE SCHEME
Period of return: From: 01/02/20 To: 31/07/20
Balance of unallotted securities under scheme(s) from previous return: 189,731
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 1,079,275
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 129,094
Equals:  Balance under scheme(s) not yet issued/allotted at end of period: 1,139,912
Name of applicant: PENNON GROUP PLC
Name of scheme: PENNON GROUP EXECUTIVE SHARE OPTION SCHEME
Period of return: From: 01/02/20 To: 31/07/20
Balance of unallotted securities under scheme(s) from previous return: 14,663
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): NIL
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): NIL
Equals:  Balance under scheme(s) not yet issued/allotted at end of period: 14,663
Name of contact: K Senior - Deputy Company Secretary
Telephone number of contact: 01392 443060

3 August 2020

www.pennon-group.co.uk

End transmission

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BLRFLFIVTAIVIII